197 343

Cited 2 times in

Treatment of drug resistant bacteria: new bugs, old drugs, and new therapeutic approaches

Other Title
내성세균의 치료: 새로운 균, 오래된 약제, 새로운 접근
Authors
최, 영화
Citation
Taehan Ŭisa Hyŏphoe chi, 57(10):837-844, 2014
Journal Title
Taehan Ŭisa Hyŏphoe chi; Journal of the Korean Medical Association; 대한의사협회지
ISSN
1975-84562093-5951
Abstract
Rapidly increasing antimicrobial resistance and lack of effective antibiotics are dilemma in the treatment of infectious diseases. Clinicians are now considering the use of old antibiotics such as colistin, fosfomycin because of limitation of therapeutic options. The unique pharmacokinetic and pharmacodynamics properties of these antibiotics have led the new therapeutic approaches, such as the combination of agents and newer dosing regimens. Colistin has become the last drug of the treatment of multidrug resistant gram-negative bacteria and the loading dose and high dose maintenance has been suggested. Tigecycline is licensed for the treatment of complicated skin and intra-abdominal infections and has broad activity against gram-positive and gram-negative pathogens but cautious use in the treatment of bloodstream infection and pneumonia is recommended. Oral and intravenous fosfomycin may be effective treatment options in the case of resistant gram-negative infections but clinical studies are limited.
Keywords
Antimicrobial resistanceColistinTigecyclineFosfomycin
DOI
10.5124/jkma.2014.57.10.837
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Infectious Diseases
AJOU Authors
최, 영화
Full Text Link
Files in This Item:
10.5124_jkma.2014.57.10.837.pdfDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse